Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for HIND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.0082M
June 30, 2025 0.00
March 31, 2025 0.014M
December 31, 2024 3.622M
September 30, 2024 0.077M
June 30, 2024 0.103M
March 31, 2024 0.127M
December 31, 2023 0.151M
September 30, 2023 0.175M
June 30, 2023 0.198M
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.086M
December 31, 2021 0.00
September 30, 2021 2.971M
Date Value
June 30, 2021 2.936M
March 31, 2021 0.774M
December 31, 2020 12.94M
September 30, 2020 0.983M
June 30, 2020 1.096M
March 31, 2020 0.969M
December 31, 2019 0.567M
September 30, 2019 0.687M
June 30, 2019 5.722M
March 31, 2019 20.77M
December 31, 2018 9.93M
September 30, 2018 9.922M
June 30, 2018 9.945M
March 31, 2018 9.934M
December 31, 2017 9.922M
September 30, 2017 9.912M
June 30, 2017 9.901M
March 31, 2017 9.891M
December 31, 2016 9.881M
September 30, 2016 9.886M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Cardiac Biotech Solutions, Inc. 0.00
Anika Therapeutics, Inc. 23.32M
Enovis Corp. 1.344B
Edwards Lifesciences Corp. 680.30M
Perspective Therapeutics, Inc. 2.866M